Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells

Janeen H. Trembley, Gretchen M. Unger, Vicci L. Korman, Diane K. Tobolt, Zygmunt Kazimierczuk, Lorenzo A. Pinna, Betsy T. Kren, Khalil Ahmed

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science